Health & Medical Cancer & Oncology

Ofatumumab as Front-Line Therapy in Untreated CLL

By Health & Medical Last updated Tuesday, June/11/2024

Ofatumumab as Front-Line Therapy in Untreated CLL

Regulatory Affairs

Ofatumumab is currently approved in the USA and the EU for the treatment of CLL patients with fludarabine- and alemtuzumab-refractory disease.

Prev Post

How to Center an Object on a Form in Visual Basic 2007

Next Post

Reliving Jim Carrey Movies

Cancer & Oncology

Human Papilloma Virus and Cervical Cancer.. The Missing Link

Cancer & Oncology

Avoiding Cancer The Natural Way With Blueberries

Cancer & Oncology

Challenges in Combining Novel Molecularly Targeted Agents

Cancer & Oncology

Risk Factors Using a Skin Cancer Screening Program

Cancer & Oncology

How to Understand and Treat Your Breast Cancer

Cancer & Oncology

Clinical Trials in Lung Cancer Surgery, Research Cooperation

Cancer & Oncology

Thyroid Cancer: Extent of Thyroidectomy

Cancer & Oncology

Prediction of Late Disease Recurrence by H/I Biomarker

Cancer & Oncology

Colon Cancer: Risks And Prevention

Cancer & Oncology

Brachytherapy India- best of technology at your service

Leave A Reply